Back to Search
Start Over
Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial
- Source :
- Clinical Infectious Diseases. 66:220-228
- Publication Year :
- 2017
- Publisher :
- Oxford University Press (OUP), 2017.
-
Abstract
- Background Tenofovir disoproxil fumarate (TDF) decreases bone mineral density (BMD). We hypothesized that vitamin D3 (VITD3) would increase BMD in youth receiving TDF. Methods This was a randomized, double-blind, placebo-controlled trial of directly observed VITD3 vs placebo every 4 weeks for 48 weeks in youth aged 16-24 years with HIV, RNA load
- Subjects :
- Male
0301 basic medicine
Microbiology (medical)
Vitamin
medicine.medical_specialty
Adolescent
Anti-HIV Agents
Calcium-Regulating Hormones and Agents
Placebo-controlled study
Parathyroid hormone
HIV Infections
Placebo
Gastroenterology
Placebos
Young Adult
03 medical and health sciences
chemistry.chemical_compound
Double-Blind Method
Bone Density
Internal medicine
medicine
Vitamin D and neurology
Humans
Tenofovir
Articles and Commentaries
Cholecalciferol
Bone mineral
Bone Density Conservation Agents
business.industry
virus diseases
030112 virology
Spine
Treatment Outcome
Infectious Diseases
chemistry
Female
business
Multivitamin
Subjects
Details
- ISSN :
- 15376591, 10584838, and 01751646
- Volume :
- 66
- Database :
- OpenAIRE
- Journal :
- Clinical Infectious Diseases
- Accession number :
- edsair.doi.dedup.....ea6e9a87c46f211138417e45111ddb5b
- Full Text :
- https://doi.org/10.1093/cid/cix753